Actinium Pharmaceuticals (ATNM) Change in Account Payables (2010 - 2015)
Actinium Pharmaceuticals (ATNM) posted quarterly Change in Account Payables of -$13539.0 for Q4 2015, up 78.82% year-over-year from -$7571.2 in Q4 2014, and down 200.0% quarter-over-quarter from $13539.0 in Q3 2015.
Actinium Pharmaceuticals (ATNM) Change in Account Payables (2010 - 2015) Analysis & Trends
Actinium Pharmaceuticals (ATNM) has reported Change in Account Payables for 6 consecutive years, with -$13539.0 the latest figure, recorded in Q4 2015.
- In Q4 2015, Change in Account Payables rose 78.82% year-over-year to -$13539.0; the TTM figure through Dec 2015 stood at -$189357.0 (down 242.19% YoY), while the FY2015 annual figure was -$189357.0, down 242.19% from the prior year.
- Change in Account Payables retreated to -$13539.0 in Q4 2015 per ATNM's latest filing, from $13539.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $108352.0 in Q1 2014 and bottomed at -$294501.0 in Q4 2013.
- Historically, Change in Account Payables has averaged -$27923.1 across 5 years, with a median of -$1000.0 in 2012.
- Annual changes were most pronounced in 2011 — Change in Account Payables tumbled 995.3% — and 2012, when it soared 117.22%.
- Actinium Pharmaceuticals' Change in Account Payables stood at -$2220.0 in 2011, then surged by 194.59% to $2100.0 in 2012, then tumbled by 14123.86% to -$294501.0 in 2013, then soared by 78.29% to -$63934.0 in 2014, then surged by 78.82% to -$13539.0 in 2015.
- Business Quant data shows ATNM's Change in Account Payables at -$13539.0 in Q4 2015, $13539.0 in Q3 2015, and -$282912.0 in Q2 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -8.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 37.53 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Actinium Pharmaceuticals | 35.01 Mn | 35.01 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | -13,539.00 |
| Dec 31, 2015 | -13,539.00 |
| Sep 30, 2015 | 13,539.00 |
| Sep 30, 2015 | 13,539.00 |
| Jun 30, 2015 | -282,912.00 |
| Jun 30, 2015 | -282,912.00 |
| Mar 31, 2015 | 93,555.00 |
| Mar 31, 2015 | 93,555.00 |
| Dec 31, 2014 | -63,934.00 |
| Dec 31, 2014 | -63,934.00 |
| Sep 30, 2014 | 88,754.00 |
| Sep 30, 2014 | 88,754.00 |
| Mar 31, 2014 | 108,352.00 |
| Mar 31, 2014 | 108,352.00 |
| Dec 31, 2013 | -294,501.00 |
| Dec 31, 2013 | -294,501.00 |
| Sep 30, 2012 | 2,100.00 |
| Sep 30, 2012 | 2,100.00 |
| Jun 30, 2012 | -1,000.00 |
| Jun 30, 2012 | -1,000.00 |